Article ; Online: Meloxicam treatment disrupts the regional structure of innate inflammation sites by targeting the pro-inflammatory effects of prostanoids.
British journal of pharmacology
2023 Volume 181, Issue 7, Page(s) 1051–1067
Abstract: Background and purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely prescribed drugs in the world due to their analgesic, antipyretic and anti-inflammatory effects. However, NSAIDs inhibit prostanoid synthesis, interfering with ... ...
Abstract | Background and purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely prescribed drugs in the world due to their analgesic, antipyretic and anti-inflammatory effects. However, NSAIDs inhibit prostanoid synthesis, interfering with their pro-inflammatory and anti-inflammatory functions and potentially prolonging acute inflammation. Experimental approach: We used high-content immunohistochemistry to define the impact of meloxicam treatment on spatially separated pro-inflammatory and anti-inflammatory processes during innate inflammation in mice induced by zymosan. This allowed us to determine the effect of meloxicam treatment on the organization of pro-inflammatory and anti-inflammatory microenvironments, thereby identifying relevant changes in immune cell localization, recruitment and activation. Key results: Meloxicam treatment reduced zymosan-induced thermal hypersensitivity at early time points but delayed its resolution. High-content immunohistochemistry revealed that the pro-inflammatory area was smaller after treatment, diminishing neutrophil recruitment, M1-like macrophage polarization, and especially phagocytosis by neutrophils and macrophages. The polarization of macrophages towards the M2-like anti-inflammatory phenotype was unaffected, and the number of anti-inflammatory eosinophils actually increased. Conclusion and implications: High-content immunohistochemistry was able to identify relevant meloxicam-mediated effects on inflammatory processes based on alterations in the regional structure of inflammation sites. Meloxicam delayed the clearance of pathogens by inhibiting pro-inflammatory processes, causing prolonged inflammation. Our data suggest that the prescription of NSAIDs as a treatment during an acute pathogen-driven inflammation should be reconsidered in patients with compromised immune systems. |
---|---|
MeSH term(s) | Humans ; Mice ; Animals ; Meloxicam/adverse effects ; Prostaglandins ; Zymosan ; Thiazoles/pharmacology ; Thiazoles/therapeutic use ; Thiazines/pharmacology ; Thiazines/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Inflammation/chemically induced ; Inflammation/drug therapy ; Anti-Inflammatory Agents/adverse effects |
Chemical Substances | Meloxicam (VG2QF83CGL) ; Prostaglandins ; Zymosan (9010-72-4) ; Thiazoles ; Thiazines ; Anti-Inflammatory Agents, Non-Steroidal ; Anti-Inflammatory Agents |
Language | English |
Publishing date | 2023-11-22 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 80081-8 |
ISSN | 1476-5381 ; 0007-1188 |
ISSN (online) | 1476-5381 |
ISSN | 0007-1188 |
DOI | 10.1111/bph.16261 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uf I Zs.146: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.